Medifast

Medifast Debt

The Debt of Medifast (MED) as of Nov 9, 2026 is 16.79 M USD. In the previous year, Debt was 16.13 M USD — a change of 4.09% (higher).

Debt

16.79 MUSD

YoY

4.09%

Last updated:

In 2025, Medifast's total debt was 16.79 M USD, a 4.09% change from the 16.13 M USD total debt recorded in the previous year.

The Medifast Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
0.00 USD
Jan 1, 2019
13.60 M USD
Jan 1, 2020
11.16 M USD
Jan 1, 2021
32.54 M USD
Jan 1, 2022
26.05 M USD
Jan 1, 2023
22.01 M USD
Jan 1, 2024
16.13 M USD
Jan 1, 2025
16.79 M USD
The Medifast Debt history
YEARDebtYoY
16.79 MUSD+4.09%
16.13 MUSD-26.74%
22.01 MUSD-15.50%
26.05 MUSD-19.95%
32.54 MUSD+191.58%
11.16 MUSD-17.94%
13.60 MUSD—
0.00USD—
0.00USD-100.00%
779,000.00USD+255.71%
219,000.00USD-53.80%
474,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medifast Stock analysis

What does Medifast do? Medifast Inc. is a leading provider of health and wellness solutions, with its headquarters in Baltimore, Maryland. The company was founded in 1980 by Dr. William Vitale and has since experienced continuous growth. Medifast's nutrition and health products are available in the United States, Canada, and Puerto Rico. Medifast is one of the most popular companies on Eulerpool.

Debt Details

Understanding Medifast's Debt Structure

Medifast's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Medifast's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Medifast’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Medifast’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Medifast stock

Debt of Medifast is 16.79 M USD in 2025.

Debt of Medifast changed from 16.13 M USD to 16.79 M USD, representing a 4.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Medifast since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Medifast historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Medifast

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Medifast